Q3 FY26 Activities Report and Appendix 4C
Filed with ASX · · 11 pages · English
Story so far
Earlier from Renerve
- Nerve Guide Matrix Enters Stage 3 of Commercial Development
- 1HFY26 Results Announcement
- 1HFY26 Appendix 4D and Half Year Report
- Q2 FY26 Activities Report and Appendix 4C
- ReNerve receives approval in Malaysia
Later from Renerve
- Quarterly Investor Presentation
- New distribution agreement for broader Hong Kong market
- ReNerve appoints distribution partner for Malaysian Market
- ReNerve appoints J4 as second Empliq manufacturing partner
- ReNerve Secures Marketing Approval in Indonesia
Follow Renerve into a list and get an email when it puts out news.
Follow Renerve